Torrent Pharmaceuticals has fully redeemed and repaid Commercial Paper (CP) of Rs 100 crore on September 23, 2019. The instrument was issued on May 17, 2019.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.